Full-Time

Sr. Director

Quality Control

Posted on 10/7/2024

ProKidney

ProKidney

201-500 employees

Develops cell therapy for chronic kidney disease

No salary listed

Senior, Expert

Winston-Salem, NC, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • A bachelor’s degree in biology, biochemistry, immunology, or molecular and cellular biology is required. An advanced degree or Ph.D. in a scientific/technical discipline is preferred.
  • 10+ years of experience in GMP regulated biopharmaceutical industry, including 10+ years in a management/leadership role. Advance or Ph.D. degree preferred.
  • Technical and regulatory understanding of biologics, gene, or cell therapy QC with an understanding of the control strategy for these drug classes.
  • Ability to work in a fast-paced and dynamic environment that will require management of multiple competing priorities while driving all projects forward and meeting program/project deliverables.
  • Strong leadership, collaboration, team building, program management and organizational skills.
  • Proven ability to develop, communicate, and execute plans and strategies with a wide range of stakeholders.
  • Excellent judgment and creative problem-solving skills, including negotiation and conflict resolution skills.
  • Excellent interpersonal, organizational, and written and oral communication skills.
  • Prior experience in a managerial capacity within QA or QC.
  • Communicate effectively and successfully handle conflict resolution.
  • Possess experience with laboratory operations, analytical transfer and validation, Pre-Approval Inspections, and product launch activities.
  • Advanced knowledge of GMPs.
  • Experience ensuring all laboratory investigations meet compliance requirements.
Responsibilities
  • Directs the development, validation, planning, implementation, and maintenance of QC product tests and analytical methods, processes, and operations.
  • Supports the design and execution of the environmental monitoring and sterility assurance programs for GMP manufacturing operations.
  • Supports development of QC tests and analytical methods that support production, including design support.
  • Validates analytical test methods for raw materials and finished goods.
  • Oversees raw material, in-process and final product release testing.
  • Responsible for ensuring the appropriate stability programs are initiated and completed to support product development and customer requirements.
  • Ensures quality control systems and equipment are compliant with standards and applicable regulatory guidelines.
  • Responsible for ensuring that project objectives are met & continuous improvement of the Analytical Laboratories.
  • Strong scientific background and experience with cellular therapies across a broad range of cell types and disease treatments (adult-derived cells, stem cells, immune cells. allogeneic, autologous, etc.).
  • Familiarity with applicable regulatory requirements and compendia concerning cGMP manufacturing and testing of human cells (21CFR210, 211, 820 and 1271; Eudralex, USP, EP and ICH).
  • Understanding of analytical method qualification and validation per USP, EP and ICH guidelines.
  • Responsible for developing and delivering training materials to ensure that all QC employees' operational, scientific, and analytical training is conducted as needed to ensure that the group is entirely and accurately trained on time for all QC activities.
  • Responsible for liaison with the Manufacturing, Quality Assurance, Supply Chain, Project Management, Facilities, and other GMP Quality Control units.
  • Provide support in resolving issues to meet project goals and deliverables.
  • Serves as primary QC contact for regulatory inspections.
  • Leads and participates in projects within the organization's objectives and project timelines and participates in cross-functional projects as the quality control subject matter expert.
  • Hires, manages, and trains staff. Plans and assigns duties to meet departmental and organizational objectives. Provides guidance and direction to staff, including appropriate training, mentoring, and development of staff.
  • Mentor’s direct reports and guide them to the next level in their careers.
  • Is the primary point of contact and SME for analytical testing and provides guidance aligned with regulatory standards and good laboratory practices.
Desired Qualifications
  • Extensive experience in a GMP/Professional environment, preferably in biologics.
  • Preferred experience in the pharmaceutical industry.
  • Prior direct supervisory/manager experience, leading large organization structures.
  • Use of Laboratory computer systems.
  • Potential previous use of GMP Quality Systems such as: MasterControl and LIMS.
  • Prioritization and problem solving.
  • Direct, control and plan tasks/projects.
  • Excellent communications skills both written and verbal format.
  • Relate to others in a team setting. Able to coach and manage experienced and inexperienced staff.

ProKidney focuses on treating Chronic Kidney Disease (CKD) through a unique cell therapy called rilparencel. This therapy aims to preserve kidney function in patients with advanced CKD, potentially delaying or eliminating the need for dialysis, which many patients currently rely on. ProKidney targets a significant healthcare issue, as over 35 million adults in the U.S. are affected by CKD, with many progressing to dialysis each year. The company is in the late stages of clinical trials for rilparencel, which has shown promise in maintaining kidney function. Unlike competitors, ProKidney is dedicated to a specific and underserved segment of the healthcare market, focusing solely on CKD treatment. The goal is to provide a viable alternative to dialysis, improving the quality of life for millions of patients.

Company Size

201-500

Company Stage

IPO

Headquarters

Winston-Salem, North Carolina

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • ProKidney raised $140 million, boosting clinical trials and R&D for rilparencel.
  • The FDA's approval of similar therapies may ease rilparencel's regulatory pathway.
  • Growing personalized medicine trends favor ProKidney's cell therapy approach.

What critics are saying

  • ProKidney's canceled Greensboro expansion may harm its reputation and stakeholder trust.
  • Increased manufacturing expenses could strain financial resources, affecting development pace.
  • Reliance on public offerings for capital may indicate potential cash flow issues.

What makes ProKidney unique

  • ProKidney is pioneering rilparencel, a novel cell therapy for CKD.
  • Rilparencel aims to delay or eliminate the need for dialysis in CKD patients.
  • ProKidney targets an underserved CKD market, addressing a critical treatment gap.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

-4%
Stock Titan
Jan 7th, 2025
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WINSTON-SALEM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) - ProKidney Corp. (Nasdaq: PROK) ("ProKidney"), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (CKD), today announced that ProKidney's CEO, Bruce Culleton, M.D., will present at the 43rd Annual J.P. Morgan Healthcare Conference.

Rhino Times
Nov 25th, 2024
The Best Laid Plans Of Mice And ProKidney...

In June 2023, ProKidney announced that the company planned to invest $485 million in a Greensboro biomedical factory that would create roughly 330 jobs - with those jobs averaging just under $75,000 a year.

Business North Carolina
Nov 22nd, 2024
ProKidney buys Winston-Salem land after passing on Greensboro deal

ProKidney's purchasing the buildings from Breit SE Industrial Propco, also known as Blackstone Real Estate Income Trust.

WFMY News 2
Nov 19th, 2024
ProKidney no longer coming to Greensboro, Chamber of Commerce confirms

ProKidney had previously planned to expand operations into Greensboro.

Bizjournals
Oct 23rd, 2024
Power 50 Five to Watch: Bruce Culleton, ProKidney

Less than six months after joining the company, Dr. Bruce Culleton was appointed CEO of ProKidney, a regenerative medicine that made one of the largest manufacturing investments in Triad history.

INACTIVE